Hints and tips:
...Yet at 30 times forward earnings, it trades at a discount to Zoetis, which is on a multiple of 45 times. This gap is understandable. Zoetis is the safer bet....
...Zoetis said it estimated the size of the veterinary diagnostic market at $3bn....
...He has also had a hand in the careers of several industry chief executives, who took top jobs at companies including Sanofi and Zoetis after working for Mr Read at Pfizer....
...It could choose to spin off the unit — as it did in 2013 with its animal health business Zoetis. It could keep it....
...For Mr Read, who became chief executive in 2010, divesting the consumer business would mark the biggest shake-up of the company since it spun out its animal health unit in 2013, creating Zoetis, which now...
...J&J’s shares were 0.1 per cent higher, while Zoetis was flat....
...In particular, Zoetis said that 5 per cent of its revenue growth came from expanding sales of Apoquel and other new pet products....
...In particular, Zoetis said 5 per cent of its revenue growth came from expanding sales of Apoquel and other new pet products....
...Now, despite being tick-sized compared with Zoetis, the $25bn market leader spun off by Pfizer in 2013, Dechra ranks among the world’s top 20 animal drug businesses....
...Merck & Co on Friday said it would buy Harrisvaccines, a private US group, while Zoetis recently acquired aquaculture specialist Pharmac from Permira for $765m....
...Several investors on Wednesday described him as a “shareholder-friendly” chief executive, citing popular moves such as spinning off Pfizer’s animal health business, Zoetis, and more than $65bn of share buybacks...
...Apoquel launched last year and proved so popular with pet owners that its manufacturer, Zoetis, could not keep up with demand....
...Both companies have so far subscribed to this theory: it is less than six months since Allergan agreed to sell its generics business to Teva for $41bn and just over two years since Pfizer spun out Zoetis...
...Another “mutually acceptable” independent director will also be added to the board, Zoetis said. “We welcome Bill to the board,” said Zoetis chief executive Juan Ramón Alaix....
...Mr Ackman’s Pershing Square has taken an 8.5 per cent stake in Zoetis....
...I think it’s highly unlikely anything is going to happen with Zoetis,” Mr Pearson says. Valeant would, however, be interested in buying an animal health group focused solely on pets....
...On the M&A front, Potash shares climbed nearly 5 per cent on news that the company was considering a takeover of German rival K+S, while Zoetis shares leapt on reports of interest from Valeant, closing up...
...From Pepsi to MSCI to Zoetis to Dow Chemical, companies are accepting activists’ nominees on to their boards rather than fight....
...Last week Mr Ackman identified Zoetis, the $22bn animal health group, as a potential acquisition target for Valeant. One person close to the Canadian group described Zoetis as a “Plan B acquisition”....
...They want a collection of businesses which will survive a flood, but there is a double meaning here, as his stock is Zoetis, which is the number one company in the animal health market....
...The largest animal health specialist is Zoetis, which was spun out from Pfizer in an initial public offering in 2013....
...Among them was Zoetis, the animal health group in which he recently amassed a stake and suggested as a Plan B target....
...Zoetis said it expected sales to range from $4.65bn to $4.75bn in 2014, compared to forecasts for $4.77bn....
...Net income fell 15 per cent to $2.33bn, hurt by the loss of revenues from the Zoetis animal health business spun off last year....
...Several businesses have already been divested, including last year’s spin-off of the group’s animal health business, now known as Zoetis, in a $2.2bn initial public offering....
International Edition